FTC investigators documented how pharmacy benefit managers imposed eye-popping markups on generic drugs used to treat deadly ...

Opinion: Miami attorney Gregg Goldfarb says wielding antitrust, fraud, and nuisance claims can help attorneys score wins in ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Health Secretary Robert F. Kennedy Jr. looks poised to win the battle over fluoride, to the dismay of dentists and oral ...

Bil Schmidtknecht blames pharmacy benefit managers for the death of his son. He won’t rest until he holds them accountable.

PBMs appeal FTC case over insulin costs The FTC alleges anticompetitive and unfair rebating practices that artificially inflate the list price of insulin.